Display search results for ** instead (1371 products)
13 Oct 2021  |  North America
Future Growth Potential Enhanced by the Pandemic and Growth Opportunities in Chronic Disease Management
Chronic diseases have continued to rise in prevalence, and the costs of managing these and treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behaviour change, several tools are necessary to sup...
USD 4,455.00 save 10 %
20 Sep 2021  |  North America
Personalized Diagnostics and Increased Healthcare Investment to Drive Market Growth Post COVID-19 Pandemic
The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of...
13 Sep 2021  |  North America
Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities
Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential
This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of ph...
09 Sep 2021  |  North America
Vendors' Integration of Support Services and Shift from Product-centric to Value-oriented Business Models will Improve ROI and Margins for Healthcare Providers
Globally, hospitals and health systems face financial pressure caused by high operating and administrative costs, declining revenue and reimbursement rates, and the increasing cost of both medical devices (due to technology advancements) and infrastructure. The COVID-19 pandemic has intensified this financial crisis as patient volumes dropped and n...
03 Sep 2021  |  North America
Value-based Renal Care to be a Key Growth Area
The global prevalence of CKD is estimated to be about 9% to 10%. Chronic Kidney Disease (CKD) is associated with poor outcomes, mainly due to the high burden of comorbidity. Along with rising aging population, increasing number of CKD patients are suffering from comorbidities such as hypertension, diabetes, heart failure, cancer, and mental ill hea...
27 Aug 2021  |  North America
Increasing Demand for Consumables and Single-use Technologies to Drive Growth in Upstream Bioprocessing
The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...
24 Aug 2021  |  North America
Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI
With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...
16 Aug 2021  |  North America
Growing Research and Development Pipelines of Emerging Biopharmaceutical and Niche Technology Providers Drive Competitive Intensity
Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives for the global drug discovery and early development outsourcing market in this study, which covers research and development (R&D) efforts, market trends, key participants, drivers and restraints of market adoption, and recent mergers and acquisitions. The report ...
04 Aug 2021  |  North America
The Intensely Competitive Landscape Necessitates the Repositioning of Value Through the Acceptance of New Business Models
As artificial intelligence (AI) solutions gain acceptance in the imaging fraternity and among senior leaders in the health systems space, competition has intensified and necessitated the creation of differentiation strategies for companies that want to improve their revenue and sustain growth. The rapid proliferation of medical imaging AI companies...
23 Jul 2021  |  North America
Transformational Growth in New Business Models After COVID-19
Patients with long-term chronic conditions and rare diseases are looking for safe, novel, and evidence-based digital treatments in their pursuit to reduce dosages and reverse triggers of adverse events. Payers and providers are looking for legitimate alternatives to expensive medication for their patient population. Life sciences (LS) companies are...